A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

NCT00725491 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Controlled Ovarian Stimulation

Interventions

DRUG: ganirelix
DRUG: triptorelin

Sponsor

Organon and Co